Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.South Korea-based Daewoong Pharmaceutical has found that its anti-parasitic drug niclosamide removed SARS-CoV-2, the novel coronavirus that causes Covid-19, from lungs in animal tests.
The company added that the drug completely cleared the infection in ferrets’ lung tissues and inhibited inflammation, according to Reuters.
The testing on ferrets was carried out for approximately three months. Daewoong Pharmaceutical plans to advance the drug into clinical trials in July.